Just in time for our #BCC2017 symposium, ribociclib receives @US_FDA approval for advanced #breastcancer… https://t.co/uWaQaXLYih

Just in time for our #BCC2017 symposium, ribociclib receives @US_FDA approval for advanced #breastcancer… https://t.co/uWaQaXLYih

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/841616115352649733
via IFTTT